Fullerene nanomaterials inhibit the allergic response
FP reports the receipt of grants/research support from AstraZeneca, Eisai, and Roche, and receipts of honoraria or consultation fees from Amgen, AstraZeneca, Daichii Sankyo, Celgene, Eisai, Eli Lilly, Exact Sciences, Gilead, Ipsen, Italfarmaco, Menarini, MSD, Novartis, Pierre Fabre, Pfizer, Roche, Seagen, Takeda, and Viatris, all outside the submitted work
A Certificate of Analysis (COA) is included with each order, documenting the HPLC chromatogram, mass spectrometry data, and batch-specific test results
References US Food and Drug Administration
Their expertise in recognizing patterns of adipose tissue distribution, assessing skin changes, and distinguishing lipedema from other disorders is critical for early and accurate diagnosis